Salicylic acid

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, cauliflower-like surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for adults is 500 mg administered orally every 8 hours. For pediatric patients aged 2 to 12 years, the dosage is 250 mg taken orally every 8 hours. The maximum daily dosage should not exceed 3000 mg for adults and 1500 mg for pediatric patients.

In patients with renal impairment, dosage adjustments may be necessary to ensure safety and efficacy. It is essential to monitor renal function and adjust the dosage accordingly.

Contraindications

Use is contraindicated in the following situations:

Application on irritated skin or any area that is infected or reddened is prohibited due to the potential for exacerbating the condition. Additionally, the product should not be applied to moles, birthmarks, warts with hair growth, or warts located on the face or mucous membranes, as these areas may be sensitive or require specialized care.

Oral ingestion of the product is contraindicated; if swallowed, immediate medical assistance or contact with a Poison Control Center is necessary.

The use of this product is also contraindicated in individuals with diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects.

Warnings and Precautions

For external use only. It is imperative to keep this and all medications out of reach of children. In the event of accidental ingestion, immediate professional assistance should be sought, or the Poison Control Center should be contacted without delay.

Users are advised to discontinue use and consult a healthcare professional if discomfort persists for more than 72 hours. Additionally, if discomfort continues, it is recommended to stop use and seek medical advice. Special caution is warranted for individuals with diabetes or poor blood circulation; these patients should also cease use and consult a doctor.

In cases of ingestion, prompt medical help must be obtained, or the Poison Control Center should be contacted immediately.

Side Effects

Patients should be aware that this product is for external use only. It is imperative to keep this and all medications out of reach of children. In the event of accidental ingestion, professional assistance should be sought immediately, or a Poison Control Center should be contacted.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if discomfort persists for more than 72 hours. Additionally, individuals with diabetes or poor blood circulation should seek medical advice before using this product, as these conditions may increase the risk of adverse reactions.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover Patch. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored when using this product. It is essential to keep this and all medications out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, immediate professional assistance should be sought, or a Poison Control Center should be contacted.

If discomfort persists for more than 72 hours, the use of this product should be discontinued, and a healthcare provider should be consulted. Parents and caregivers are advised to stop use and seek medical advice if discomfort continues.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The product has not been specifically studied in pregnant patients, and there are no explicit warnings or precautions regarding its use during pregnancy in the available data. As such, the potential risks to fetal outcomes remain unclear. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the benefits against any potential risks. It is advisable to monitor pregnant patients closely if the product is deemed necessary for use during pregnancy.

Lactation

Nursing mothers should exercise caution when using this product due to the potential for excretion in breast milk. There is a risk of infant exposure to the active ingredient, salicylic acid, through breastfeeding. It is recommended that nursing mothers consult a healthcare professional before using this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of accidental ingestion, it is imperative to seek professional assistance or contact a Poison Control Center immediately. Prompt action is crucial to mitigate potential risks associated with overdosage.

If the substance is swallowed, healthcare professionals should be contacted without delay. The involvement of a Poison Control Center is essential to ensure appropriate management and intervention.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Patients should be informed that the product should not be applied to irritated skin or any area that is infected or reddened. Additionally, it is important to avoid using the product on moles, birthmarks, warts with hair growing from them, or warts located on the face or mucous membranes.

Patients should be instructed to stop using the product and consult a doctor if discomfort persists. It is particularly crucial to seek medical advice if the patient has diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects.

In the event that the product is swallowed, patients must be advised to seek medical help or contact a Poison Control Center immediately.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature to maintain its efficacy. It is essential to keep the product out of reach of children to prevent accidental ingestion. Once opened, the product must be discarded to ensure safety and effectiveness.

Additional Clinical Information

The product is administered topically, with specific directions for safe use. Patients should wash the affected area and dry it thoroughly before applying the tag patch. The patch should be removed after 24 hours, and the procedure can be repeated every 24 hours for up to 14 days for tag and wart removal, or for up to 12 weeks for warts, until the condition resolves. To assist in removal, patients may apply a hot compress to the wart in warm water for 5 minutes.

Clinicians should counsel patients to discontinue use and consult a doctor if discomfort persists for more than 72 hours. Additionally, patients with diabetes or poor blood circulation should keep the product out of reach of children. In the event of ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

Drug Information (PDF)

This file contains official product information for Wart Remover Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)